FDA Sets Clinical Requirements for Gonorrhea Treatments

Clinical Trials Advisor
A A
The primary efficacy endpoint in clinical trials for uncomplicated gonorrhea should be a negative culture at the infection site three to seven days after receiving antibacterial drug therapy, the FDA says.

To View This Article:

Login

Subscribe To Clinical Trials Advisor